when intellia therapeutics submit bla for lonvo-z
before December
when intellia therapeutics submit bla for lonvo-z. Best Yes near 71¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 71¢ · Best No: 38¢ · 1 platform
- Kalshi: Yes 71¢ / No 38¢
LIVE
before December
Volume
$649
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Dec 1, 2026
~169 days left
Category
Culture
Yes
71¢
Kalshi
No
38¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Dec 1, 2026, then the market resolves to Yes.
Market Details
ResolutionResolves Dec 1, 2026
Time Left169 days
Status● Active
CategoryCulture
Yes
71¢
Kalshi
Payout 1.4x
No
38¢
Kalshi
Payout 2.6x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In